A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Translating the concept of peptide labeling with 5-deoxy-5-[F-18] fluororibose into preclinical practice: F-18-labeling of Siglec-9 peptide for PET imaging of inflammation
Tekijät: Li XG, Autio A, Ahtinen H, Helariutta K, Liljenback H, Jalkanen S, Roivainen A, Airaksinen AJ
Kustantaja: ROYAL SOC CHEMISTRY
Julkaisuvuosi: 2013
Journal: Chemical Communications
Tietokannassa oleva lehden nimi: CHEMICAL COMMUNICATIONS
Lehden akronyymi: CHEM COMMUN
Numero sarjassa: 35
Vuosikerta: 49
Numero: 35
Aloitussivu: 3682
Lopetussivu: 3684
Sivujen määrä: 3
ISSN: 1359-7345
DOI: https://doi.org/10.1039/c3cc40738a
Tiivistelmä
Peptide glycosylation with 5-deoxy-5-[F-18]fluororibose was translated into preclinical settings. The novel F-18-labeled Siglec-9 peptide was produced using an automated synthesis procedure. The F-18-labeled Siglec-9 peptide showed favorable binding in the animal model of inflammation in vivo.
Peptide glycosylation with 5-deoxy-5-[F-18]fluororibose was translated into preclinical settings. The novel F-18-labeled Siglec-9 peptide was produced using an automated synthesis procedure. The F-18-labeled Siglec-9 peptide showed favorable binding in the animal model of inflammation in vivo.